Nivolumab alone superior to ipilimumab alone in advanced melanoma
Nivolumab alone superior to ipilimumab alone in advanced melanoma
New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma
Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma
ASCO 2015: Latest developments in multiple myeloma
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer
ASCO 2015: Latest in chronic lymphocytic leukaemia
Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma
Initial nivolumab-based treatment halts melanoma progression
New intelligence network that supports efforts to improve quality of care and development of new medicines
Non-randomised clinical trial aims to describe the safety and efficacy of commercially available, targeted anticancer drugs
Advanced DNA sequencing test used to match rare cancers